![Andrew Grethlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Grethlein
Keine laufenden Positionen mehr
Vermögen: - $ am 31.07.2026
Profil
Andrew J.
Grethlein worked as Manager-Biologics Development & Manufacturing at Athena Neurosciences LLC from 1995 to 1997.
From 1997 to 2003, served as Senior Director-South San Francisco Pharmaceutical at Elan Corp.
Plc.
Held the position of Senior Vice President-Pharmaceutical Operations at Tercica, Inc. from 2003 to 2008.
From 2008 to 2010, was Senior Vice President-Hematology at Ipsen SA. Served as Chief Operating Officer & Executive Vice President at Inspiration Biopharmaceuticals, Inc. from 2010 to 2012.
Worked as Principal at Ipsen International GmbH.
From 2019 to 2025, held the role of Chief Operating Officer & Executive Vice President at Geron Corp.
Education includes undergraduate degrees from Bard College at Simon's Rock and Bates College, and graduate and doctorate degrees from Michigan State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GERON CORPORATION -.--% | 26.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Ehemalige bekannte Positionen von Andrew Grethlein
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Geschäftsführer | 15.10.2025 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Geschäftsführer | 01.09.2012 |
| IPSEN | Corporate Officer/Principal | 01.01.2010 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Andrew Grethlein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen International GmbH
 Ipsen International GmbH Industrial MachineryProducer Manufacturing Manufactures and distributes furnaces and plant systems | Producer Manufacturing |
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bard College at Simon's Rock
 Bard College at Simon's Rock Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
